China
Africa
Explore chapters and articles related to this topic
Main Classes of Drugs
Published in Jerome Z. Litt, Neil H. Shear, Litt's Drug Eruption & Reaction Manual, 2017
ACE inhibitorBenazeprilCaptoprilCilazaprilEnalaprilFosinoprilImidaprilLisinoprilMoexiprilPerindoprilQuinaprilRamiprilTrandolaprilZofenopril
Cardiovascular drugs
Published in Ann Richards, Nursing & Health Survival Guide, 2014
Captopril, cilazapril, enalapril, fosinopril, imidapril, lisinopril, moexipril, perindopril, quinapril, ramipril, trandolaprilRenin, released by the kidney, converts angiotensinogen (produced in the liver) into angiotensin I.Angiotensin I is converted to angiotensin II by angiotensin converting enzyme (ACE).Angiotensin II is a powerful vasoconstrictor and raises blood pressure (BP).Angiotensin II also increases the release of aldosterone from the adrenal cortex. This leads to sodium and water retention, thus raising BP, and potassium loss.ACE-inhibitors inhibit the enzyme ACE and so prevent the formation of angiotensin II by this route.Vasoconstriction does not occur – but vasodilation does.Sodium and water are not retained and some diuresis occurs. Potassium is retained.
Commonly prescribed drugs
Published in Alistair Burns, Michael A Horan, John E Clague, Gillian McLean, Geriatric Medicine for Old-Age Psychiatrists, 2005
Alistair Burns, Michael A Horan, John E Clague, Gillian McLean
Angiotensin-converting enzyme inhibitors (ACEIs) inhibit the conversi�n of angiotensin I to angiotensin II (captopril, cilazapril, enalapril maleate, fos- inopril, imidapril, lisinopril, moexipril hydrochloride, perindopril, quinapril, ramipril and trandolapril).
Angiotensin converting enzyme and angiotensin converting enzyme inhibitors in dermatology: a narrative review
Published in Expert Review of Clinical Pharmacology, 2022
A literature search was conducted in PubMed, Embase and Google Scholar for relevant studies from 1985 to 5 July 2021 using the index words, ‘angiotensin converting enzyme inhibitors,’ ‘angiotensin II receptor blockers,’ ‘renin angiotensin system’ and the co-indexing terms ‘treatment,’ ‘captopril,’ ‘enalapril,’ ‘lisinopril,’ ‘ramipril,’ ‘perindopril,’ ‘trandolapril,’ ‘benazepril,’ ‘quinapril,’ ’fosinopril’, ‘imidapril,’ ‘zofenopril,’ ‘cilazapril,’ ‘moexipril,’ ‘cutaneous reaction’ and ‘dermatology.’ This review article was divided into three parts. The first part discusses the clinical use of ACEI in dermatology (Table 1, 2) (Figure 1). The second part describes the relationship between ACE and immune diseases, and further discusses the possible relationship between the clinical use of ACEI for these diseases and ACE (Table 3). The third part focuses on the cutaneous adverse reactions of ACEI.